Cure My Disease

Don't miss your cure!

Home News About
Log in / Sign up
← Back to home

RAS PATHWAY

Clinical trials for RAS PATHWAY explained in plain language.

Never miss a new study

Get alerted when new RAS PATHWAY trials appear

Sign up with your email to follow new studies for RAS PATHWAY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1
Sort by
  • New Triple-Drug attack on tough endometrial cancer begins testing

    Disease control Not yet recruiting

    This early-phase study aims to find a safe and effective dose of a three-drug combination (avutometinib, defactinib, and everolimus) for people with recurrent endometrial cancer that has specific genetic changes in the RAS pathway. It will enroll about 31 participants who have al…

    Matched conditions: RAS PATHWAY

    Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

    Last updated Mar 23, 2026 15:18 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Terms of use Contact us

This is a site from Cyber and Space